MED22 anticorps (N-Term)
Aperçu rapide pour MED22 anticorps (N-Term) (ABIN2313758)
Antigène
Voir toutes MED22 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 7-36, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- MED22, NT (MED22, SURF5, Mediator of RNA polymerase II transcription subunit 22, Mediator complex subunit 22, Surfeit locus protein 5)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- MED22 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 7-36 amino acids from the N-terminal region of human MED22.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MED22 (Mediator Complex Subunit 22 (MED22))
-
Autre désignation
- MED22
-
NCBI Accession
- NP_598395, NP_852468
-
UniProt
- Q15528
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-